OTC · BSYI
BioSyntech, Inc.
$0.00$0.00 (0.0%)
BioSyntech, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
Loading market information…
OTC · HMGN · USD
Stock price
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Hemagen Diagnostics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.84% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Hemagen Diagnostics, Inc., a global biotechnology firm, specializes in delivering clinical diagnostic solutions for both human and animal health. The company designs, manufactures, and distributes the VIRGO product line, a series of human clinical immunoassays used for identifying autoimmune and infectious diseases, as well as acute phase proteins. Its comprehensive human diagnostic portfolio also encompasses Universal IFA components, various supplies, controls, calibrators, accessories, H-rotors, reagents, electrodes, equipment, and specialized assays covering conditions such as Chagas, acute phase proteins, and cytokines. For the veterinary market, Hemagen Diagnostics provides diagnostic equipment, reagents, consumables, accessories, and electrodes crucial for chemistry, hematology, and electrolyte analysis. The company reaches a diverse customer base, including laboratories, hospitals, and blood banks, through both direct sales and an extensive distribution network. Established in 1985, Hemagen Diagnostics maintains its headquarters in Columbia, Maryland.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:43 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
BioSyntech, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
SFLMaven Corp.: Financial Services · Shell Companies.
$0.01-$0.00 (-0.89%)
Qrons Inc.’s quoted price sits in the lower half of its reported 52-week range, 93.58% below the high.
$0.00-$0.00 (-25.0%)
GelStat Corporation’s quoted price sits in the upper half of its reported 52-week range, 25.0% below the high.
$0.00$0.00 (0.0%)
Garrison Film Productions Inc.’s quoted price sits in the lower half of its reported 52-week range, 58.75% below the high.
$0.00$0.00 (0.0%)
ViaDerma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.75% below the high.
$0.00$0.00 (0.0%)
Nascent Biotech, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.85% below the high.
$0.00$0.00 (0.0%)
Quantum Medical Transport, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
